info@guardianresearch.org
Contact Us
Careers
864-777-7165
Close Menu →
Health Systems
Who we are
What we do
How we do it
What you get
What makes us different
LIFE SCIENCES
Who we are
What we do
How we do it
What makes us different
OFFERINGS
Health Systems Offerings
Life Sciences Offerings
Transforming Data
About us
Resources
Resources
Publications
Blog
News
Donate
Contact Us
info@guardianresearch.org
864-777-7165
Disease:
Non–Small Cell Lung Cancer (NSCLC)
All Diseases
Acute Myeloid Leukemia
AML
Breast Cancer
Cancer
Chronic Lymphocytic Leukemia
Diagnostics
Hematologic Cancers
Lung Cancer
Lymphoma
Mature B Cell Malignancy
Metastatic Non–Small Cell Lung Cancer
Multiple Myeloma
Multiple Oncology
NHL
Non–Small Cell Lung Cancer (NSCLC)
Other Cancers
Primary Central Nervous System Lymphoma
Sarcoma
All Publications
Annals of Oncology
ASCO
Blood
Blood Cancer Journal
British Journal of Clinical Pharmacology
Clinical Drug Investigation
HemaSphere
Journal of Clinical Oncology
Journal of the National Comprehensive Cancer Network
MDPI
ScienceDirect
Springer Nature
Taylor & Francis
Value in Health
Back
HER3 is Widely Expressed Across Diverse Subtypes of NSCLC in a Retrospective Analysis of Archived Tissue Samples
Disease:
Non–Small Cell Lung Cancer (NSCLC)
Publication:
Taylor & Francis
Abstract
10 Sep, 2024
© 2025 Guardian Research Network- All Rights Reserved
|
Legal
